Utility of formaldehyde-fixed arterial allografts for hemodialysis access.
Roy-Chaudhury
Prabir
P
University of Cincinnati, Division of Nephrology, MSB G251, 231 Albert Sabin Way, Cincinnati, OH 45267-0585, USA. roychap@ucmail.uc.edu
D000328:Adult; D001158:Arteries / Q000637:transplantation*; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects* / Q000191:economics; D001808:Blood Vessels / Q000637:transplantation; D002102:Cadaver; D002408:Catheters, Indwelling / Q000191:economics; D017046:Cost Savings; D004502:Education, Medical, Continuing; D005260:Female; D005500:Follow-Up Studies; D005557:Formaldehyde / Q000494:pharmacology*; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000379:methods; D018570:Risk Assessment; D014021:Tissue Preservation / Q000191:economics / Q000379:methods; D014184:Transplantation, Homologous / Q000191:economics; D014481:United States; D014654:Vascular Patency
D005557:Formaldehyde